Lantern Pharma Inc.
LTRN- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001763950
No open-market purchases or sales by Lantern Pharma Inc. insiders were filed in the last 90 days; 39 institutions reported holding it in 13F filings for Q2 2026, worth $12.0M in total; no superinvestor holds it.
13F holders, Q2 2026
Institutional positions in Lantern Pharma Inc. as of Jun 30, 2026. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 39
- +6 vs. Q1 2026
- Shares held
- 2.88M
- +786.2K (+37.5%) vs. Q1 2026
- Total value
- $12.0M
- +$9.15M (+318.5%) vs. Q1 2026
- New holders
- 12
- 9 more added
- Sold out
- 6
- 8 more reduced
Compare with Q1 2026: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting LTRN on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 39 | $12.0M |
| Q1 2026 | 33 | $2.87M |
| Q4 2025 | 33 | $6.91M |
| Q3 2025 | 30 | $9.89M |
| Q2 2025 | 35 | $7.11M |
| Q1 2025 | 32 | $8.62M |
| Q4 2024 | 32 | $8.00M |
| Q3 2024 | 31 | $4.90M |
| Q2 2024 | 39 | $6.01M |
| Q1 2024 | 34 | $9.75M |
| Q4 2023 | 30 | $4.94M |
| Q3 2023 | 27 | $3.93M |
| Q2 2023 | 25 | $6.50M |
| Q1 2023 | 21 | $5.23M |
| Q4 2022 | 23 | $5.40M |
| Q3 2022 | 26 | $6.84M |
| Q2 2022 | 26 | $8.06M |
| Q1 2022 | 25 | $10.4M |
| Q4 2021 | 33 | $13.1M |
| Q3 2021 | 25 | $15.7M |
| Q2 2021 | 22 | $19.7M |
| Q1 2021 | 24 | $25.5M |
Institutions, Q2 2026
Shares, value and share of portfolio for each institution holding Lantern Pharma Inc.; share changes are against Q1 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Key Financial Inc | 2 | $8 | 0.00% | 00.0% | Unchanged |
| Barclays PLC | 6 | $25 | 0.00% | +6 | New |
| Group One Trading, L.P. | 23 | $96 | 0.00% | 00.0% | Unchanged |
| PlanVest Financial, Inc | 100 | $417 | 0.00% | +100 | New |
| Rialto Wealth Management, LLC | 123 | $513 | 0.00% | +123 | New |
| UMA Financial Services, Inc. | 158 | $659 | 0.00% | +158 | New |
| Advisor Group Holdings, Inc. | 220 | $917 | 0.00% | 00.0% | Unchanged |
| Northwestern Mutual Wealth Management Co | 500 | $2.08K | 0.00% | 00.0% | Unchanged |
| Entrust Financial LLC | 500 | $2.08K | 0.00% | +500 | New |
| Morgan Stanley | 639 | $2.67K | 0.00% | +38+6.3% | Added |
| Tower Research Capital LLC (TRC) | 1,162 | $4.85K | 0.00% | −2,407−67.4% | Reduced |
| SBI Securities Co., Ltd. | 2,159 | $9.00K | 0.00% | +15+0.7% | Added |
| Simplex Trading, LLC | 2,337 | $9.74K | 0.00% | +2,230+2,084.1% | Added |
| Vanguard Global Advisers, LLC | 2,355 | $9.82K | 0.00% | 00.0% | Unchanged |
| Farther Finance Advisors, LLC | 10,975 | $45.8K | 0.00% | +10,975 | New |
| Marshall Wace, LLP | 11,946 | $49.8K | 0.00% | +11,946 | New |
| Cetera Investment Advisers | 12,228 | $51.0K | 0.00% | 00.0% | Unchanged |
| Susquehanna International Group, LLP | 14,073 | $58.7K | 0.00% | +14,073 | New |
| Colony Group, LLC | 15,432 | $64.4K | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 16,632 | $69.4K | 0.00% | +6,555+65.0% | Added |
| Dimensional Fund Advisors LP | 16,725 | $69.7K | 0.00% | −21,335−56.1% | Reduced |
| XTX Topco Ltd | 17,415 | $72.6K | 0.00% | +17,415 | New |
| Northern Trust Corp | 17,485 | $72.9K | 0.00% | +1,896+12.2% | Added |
| Bank of New York Mellon Corp | 21,301 | $88.8K | 0.00% | 00.0% | Unchanged |
| BlackRock, Inc. | 22,350 | $93.2K | 0.00% | −22,917−50.6% | Reduced |
| State Street Corp | 23,652 | $98.6K | 0.00% | 00.0% | Unchanged |
| Davenport & Co LLC | 23,814 | $99.3K | 0.00% | 00.0% | Unchanged |
| Horizon Kinetics Asset Management LLC | 25,164 | $104.9K | 0.00% | −1,209−4.6% | Reduced |
| GWM Advisors LLC | 27,049 | $112.8K | 0.00% | −350−1.3% | Reduced |
| Quadrature Capital Ltd | 39,593 | $165.1K | 0.00% | +39,593 | New |
| Westside Investment Management, Inc. | 47,850 | $199.5K | 0.03% | −2,200−4.4% | Reduced |
| Citadel Advisors LLC | 47,895 | $199.7K | 0.00% | +47,895 | New |
| Vanguard Fiduciary Trust Co | 49,950 | $208.3K | 0.00% | +343+0.7% | Added |
| Geode Capital Management, LLC | 102,819 | $428.9K | 0.00% | −8,827−7.9% | Reduced |
| BIOS Capital Management, LP | 249,397 | $1.04M | 2.50% | −615,038−71.1% | Reduced |
| Renaissance Technologies LLC | 291,039 | $1.21M | 0.00% | +175,039+150.9% | Added |
| Vanguard Capital Management LLC | 425,118 | $1.77M | 0.00% | +93,039+28.0% | Added |
| CM Management, LLC | 500,000 | $2.08M | 1.32% | +250,000+100.0% | Added |
| Empery Asset Management, LP | 842,669 | $3.51M | 4.06% | +842,669 | New |
| Voss Capital, LLC | 0 | $0 | 0.00% | −50,000−100.0% | Sold out |
| Curio Wealth, LLC | 0 | $0 | 0.00% | −2,000−100.0% | Sold out |
| Wells Fargo & Company | 0 | $0 | 0.00% | −1,475−100.0% | Sold out |
| FMR LLC | 0 | $0 | 0.00% | −500−100.0% | Sold out |
| JPMorgan Chase & Co | 0 | $0 | 0.00% | −97−100.0% | Sold out |
| Citigroup Inc | 0 | $0 | 0.00% | −45−100.0% | Sold out |